EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation

Journal:
Cell
Published:
Affiliations:
21
Authors:
26
Institutions Authors Share
State Key Laboratory of Immune Response and Immunotherapy, China
4.500000
0.17
Cellerys AG, Switzerland
2.200000
0.08
One Lambda, Inc., United States of America (USA)
2.000000
0.08
University Children's Hospital of Zurich, Switzerland
2.000000
0.08
Cluster of Excellence "Image-guided and Functionally Instructed Tumor Therapies" (iFIT), Germany
1.750000
0.07
University of Zurich (UZH), Switzerland
1.700000
0.07
University Hospital Tübingen (UKT), Uni Tübingen, Germany
1.666667
0.06
Imperial College London (ICL), United Kingdom (UK)
1.500000
0.06
DKTK Partner Site Tuebingen, Germany
1.250000
0.05
University Hospital Zurich (UHZ), Switzerland
1.200000
0.05
Hefei Comprehensive National Science Center, China
1.000000
0.04
Functional Genomics Center Zurich (FGCZ), Switzerland
1.000000
0.04
Shenzhen University of Advanced Technology (SUAT), China
1.000000
0.04
National Center for Tumor Diseases (NCT) Heidelberg, Germany
1.000000
0.04
First Affiliated Hospital, AHMU, China
0.500000
0.02
Immunity and Cancer Unit, France
0.500000
0.02
University of Verona (UNIVR), Italy
0.500000
0.02
University of Tübingen (Uni Tübingen), Germany
0.333333
0.01
Center for Molecular Medicine (CMM), Sweden
0.200000
0.01
Karolinska Institute (KI), Sweden
0.200000
0.01